Healthcare -
Biotechnology - NASDAQ - US
$ 79.05
-3.07 %
$ 14.3 B
Market Cap
-14.19
P/E
INSM - REVENUE
Revenue INSM - Insmed Incorporated
364 M
LAST VALUE
21.75%
2 YEAR CAGR
21.66%
5 YEAR CAGR
41.26%
10 YEAR CAGR